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Many Gram-positive bacteria covalently tether their surface ad-
hesins to the cell wall peptidoglycan. We find that surface proteins
of Staphylococcus aureus are linked to the cell wall by sortase, an
enzyme that cleaves polypeptides at a conserved LPXTG motif.
S. aureus mutants lacking sortase fail to process and display surface
proteins and are defective in the establishment of infections. Thus,
the cell wall envelope of Gram-positive bacteria represents a
surface organelle responsible for interactions with the host envi-
ronment during the pathogenesis of bacterial infections.
Gram-positive bacteria are surrounded by a cell wall envelopecontaining attached polypeptides and polysaccharides (1).
Although surface proteins of Gram-positive bacteria have long
been characterized as adhesins for human tissues, the mecha-
nism of their cell wall attachment and surface display has only
recently been described. Protein A, a surface protein of Staph-
ylococcus aureus (2), is synthesized as a precursor bearing an
N-terminal signal peptide and a C-terminal sorting signal with an
LPXTG motif (3). After signal peptide-mediated initiation of
the precursor into the secretory pathway, the sorting signal
directs protein A to the cell wall envelope (4). The polypeptide
is then cleaved between the threonine and the glycine of the
LPXTG motif (5). The liberated carboxyl group of threonine
forms an amide bond with the amino group of the pentaglycine
crossbridge (6), thereby tethering the C terminus of protein A to
the bacterial peptidoglycan (7, 8).
To identify genes that act in the sorting pathway of protein A,
temperature-sensitive staphylococcal mutants were pulse-
labeled and screened for a defect in protein A precursor
processing (9). A mutant S. aureus strain was identified, trans-
formed with a plasmid library of staphylococcal genomic DNA,
and screened for complementation. The srtA gene (surface
protein sorting A) restored the defect in cell wall anchoring of
protein A (9). Furthermore, purified SrtA catalyzed the in vitro
cleavage of peptides bearing the LPXTG motif (10). These
results suggest that srtA encodes sortase, a transpeptidase re-
sponsible for processing the sorting signal of protein A.
The genome of S. aureus encodes at least 10 different surface
proteins bearing C-terminal sorting signals with an LPXTG
motif (11). Many of these polypeptides are known to interact
with various human tissues, serum proteins, or polypeptides of
the extracellular matrix (12). For example, protein A (Spa) binds
to the Fc portion of immunoglobulins (13), a mechanism that is
thought to prevent opsonophagocytosis of staphylococci after
their entry into the human host (14, 15). Binding of the clumping
factors, ClfA and ClfB, to fibrinogen promotes bacterial adhe-
sion to vascular and endocardic lesions (16–18). The FnbA and
FnbB surface proteins bind to fibronectin (19, 20). This inter-
action allows staphylococci to adhere to various tissues and,
similar to fibronectin-binding proteins of Streptococcus pyogenes
(21), presumably provides for the invasion and apoptotic death
of infected epithelial cells (22). Although all of these surface
proteins are thought to be essential for the pathogenesis of
staphylococcal infections (12), this assumption has not been
demonstrated for surface protein knockout strains in animal
models of infection (15, 23). Presumably, surface proteins of
S. aureus fulfill at least partially redundant functions.
Previous work left unresolved whether srtA is absolutely
required for the anchoring of surface proteins to the cell wall
envelope. We find that S. aureus mutants lacking the srtA gene
fail to anchor all surface proteins examined because of a defect
in the processing of sorting signals at the LPXTG motif. As a
result, the assembly and display of surface adhesins is abolished,
causing a reduction in the ability of sortase mutants to establish
animal infections.
Experimental Procedures
Bacterial Strains and Plasmids. S. aureus strains RN4220 (res2)
(24), OS2 (spa2:ermC) (3), and Newman (25) have been de-
scribed. srtA sequences were PCR amplified with the primers
GSA1–4 (AAGGATCCAAAAGGAGCGGTATACATTGC)
and orf6-3K (AAAGGTACCGTGTACTTTAAAGTTGGTA-
ATG) as well as orf6-5K (AAAGGTACCCTTTTTATCTT-
TACTCGCC) and orf6-3E (AAAGAATTCGAACCACTA-
CATAATAAATC). The DNA fragments were digested with
BamHI and KpnI or EcoRI and KpnI, ligated, and inserted
between the EcoRI and BamHI sites of pTS1 (26) to generate
pSM29. ermC was PCR amplified with the primers ErmC-59
(AAAGGTACCTACACCTCCGGATAATAAA) and
ErmC-39 (AAAGGTACCCACAAGACACTCTTTTTTC).
The KpnI-digested DNA fragment was inserted into pSM29 to
yield pSrtA-KO. RN4220 (pSrtA-KO) was plated at 42°C on
erythromycin plates (10 mgyml). Colonies were picked and
analyzed by PCR using the primer pairs GSA1–4yorf6-3E and
ErmC-59yErmC-39. Plasmids pSeb-SpaKpnI and pSeb-FnbA have
been described previously (4). pSeb-ClfA was constructed by
PCR amplification of a DNA segment specifying the clumping
factor sorting signal. The PCR product was digested with KpnI
and BamHI and inserted into pSeb-SpaKpnI cut with the same
restriction enzymes. Plasmids pSebSP-BlaZ (27), pSeb-Cws-
BlaZ, and pSeb-CwsDLPXTG-BlaZ (5) have been previously con-
structed. To generate pSeb-CwsDR-BlaZ, the Spa sorting signal
was PCR amplified with the primers Seb-5 (AAGGTACCTT-
TCTTTGTCGTAAGATAAACTTCA) and T-Sac (AA-
GAGCTCCCAGCTAATGCTGCACCT), cut with KpnI–SacI,
and inserted into pSeb-Cws-BlaZ cut with the same restriction
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enzymes. Pulse–chase, cell fractionation, and cell wall linkage
assay were performed as previously described (4).
Immunofluorescence Microscopy. Staphylococci were grown in
TSB, washed with PBS, and applied to poly-L-lysine-coated glass
slides. Slides were washed with PBS, blocked for 1 h with 2%
BSA in PBS, and incubated with a 1:1,000 dilution of CY3-
labeled IgG in PBSyBSA for 1 h. Slides were washed with PBS
and viewed under fluorescence excitation, and images were
captured with a charge-coupled device camera.
Animal Experiments. Staphylococci were grown overnight in tryp-
tic soy broth (TSB), diluted into fresh medium, grown for 3 h at
37°C to OD600 0.5, and washed and diluted in PBS. Six- to
eight-week-old C57BLy6 mice or Swiss–Webster mice were
inoculated with 500 ml of staphylococcal suspension into the tail
vein. Five days after infection, mice were euthanized with CO2.
Kidneys were excised, weighed, and homogenized in 0.5% Triton
X-100. Staphylococci were counted by dilution and colony
formation. All experiments used staphylococcal strains that were
subjected to animal passage and isolated from the kidneys of
infected mice. All mice were treated in accordance with the
institutional guidelines for the humane care and treatment of
animals.
Results
Staphylococcal Sortase. To generate knockout mutations of sor-
tase, the ermC gene, f lanked by srtA nucleotide sequences, was
cloned into an Escherichia coli–S. aureus shuttle plasmid that is
temperature-sensitive for replication (26). Homologous recom-
bination caused the insertion of ermC into the genome of
S. aureus RN4220, replacing codons 52–142 of srtA with ermC.
To facilitate virulence studies, the srtA:ermC allele was trans-
duced with phage F85 into S. aureus Newman, a strain previously
isolated from a human infection (25). Transductants were se-
lected on erythromycin plates and analyzed by PCR amplifica-
tion with primers that anneal to ermC or to sequences flanking
the srtA gene (Fig. 1A). The ermC gene could be amplified from
the chromosomal DNA of the srtA2 mutant strains SKM1 and
SKM3 but not from the isogenic parent strains RN4220 and
Newman. Amplification with primers specific for sequences
flanking srtA revealed the insertion of ermC into the srtA genes
of strains SKM1 and SKM3.
Recombinant sortase lacking the N-terminal signal peptide
(SrtADN) was purified from the cytoplasm of E. coli and used to
raise specific antibodies (10). Immunoblotting of staphylococcal
extracts with a-SrtA revealed that sortase is a polypeptide of
26 kDa (Fig. 1B). Wild-type sortase migrated more slowly on
SDSyPAGE than SrtADN, suggesting that the N-terminal signal
peptide of sortase was not cleaved. The srtA2 strains SKM1 and
SKM3 did not express sortase, however, transformation of the
mutant staphylococci with plasmid-encoded wild-type srtA re-
stored expression. To localize sortase within staphylococci,
S. aureus RN4220 cultures were fractionated into the extracel-
lular medium (MD), cell wall digest (CW), cytosol (C), and
membrane compartments (M) (Fig. 1C). Sortase was found only
in the membrane, suggesting that the N-terminal signal peptide
functions also as a membrane anchor.
Anchoring Surface Proteins to the Cell Wall of S. aureus. To test
whether sortase mutants are defective in the anchoring of
staphylococcal surface proteins, we investigated the processing
of C-terminal sorting signals by pulse-labeling staphylococcal
cultures. Sorting signals of protein A (Spa), fibronectin-binding
protein (FnbA), and clumping factor (ClfA) were fused to the C
terminus of the normally secreted enterotoxin B reporter pro-
tein. Wild-type staphylococci exported surface protein precursor
(P1) from the cytoplasm and removed the N-terminal signal
peptide to generate the P2 intermediate. P2 was cleaved by
sortase at the LPXTG motif to generate mature, cell wall-
anchored surface protein (M) (Fig. 2). Wild-type staphylococci
cleaved the Spa, FnbA, and ClfA sorting signals to generate
mature surface protein (Fig. 2B). In contrast, the sortase mutant
strains SKM1 and SKM3 (srtA2) failed to cleave all P2 surface
protein precursors. Transformation of sortase mutant strains
with plasmids encoding wild-type srtA restored the processing of
C-terminal sorting signals.
As sortase mutant staphylococci cannot process C-terminal
sorting signals, these strains are likely defective in anchoring
surface proteins to the cell wall envelope. The subcellular
location of surface proteins was examined by fractionating
pulse-labeled staphylococci into the medium, cell wall, cyto-
plasm, and membrane compartments. Wild-type staphylococci
anchored surface proteins to the cell wall envelope. In contrast,
sortase mutant staphylococci mislocalized surface proteins, and
the P2 precursors were immunoprecipitated from the cytoplasm,
membrane, and cell wall compartment (Fig. 2C). This phenotype
is identical to the missorting of protein A mutants lacking the
LPXTG motif. As the LPXTG mutant is not stably inserted into
Fig. 1. S. aureus sortase (srtA) mutants. (A) Drawing depicts the wild-type
sortase (srtA) gene (1) and the srtA2:ermC allele (2). Plasmid-encoded wild-
type srtA (pSrtA) is expressed from its own promoter and was used for
complementation studies (3). Oligonucleotide primers binding to sequences
flanking the srtA gene (filled arrows) or the ermC gene (open arrows) were
used to amplify DNA fragments from the chromosomal DNA of strains RN4220
(srtA, 1), SKM1 (srtA2, 2), Newman (srtA, 1), and SKM3 (srtA2, 2). DNA
fragments were separated on ethidium bromide-stained agarose gel, flanked
by the 1-kb DNA ladder. (B) Immunoblotting with anti-SrtA (a-SrtA) revealed
the presence of sortase (26 kDa) in extracts of wild-type strains RN4220 and
Newman and the absence of sortase in the mutant strains SKM1 and SKM3
(srtA2). SrtADN lacking the N-terminal membrane anchor was expressed in
E. coli and purified. (C) RN4220 cultures were fractionated into medium (MD),
cell wall (CW), membrane (M), and cytosolic (C) compartments and immuno-
blotted with a-SrtA.
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the cytoplasmic membrane, the polypeptide appears during
fractionation in several different compartments (3). To measure
the covalent linkage of surface proteins to the cell wall, the
staphylococcal peptidoglycan was digested with two different
enzymes (Fig. 2D). Lysostaphin (L) cut at the pentaglycine
crossbridge (28) and released cell wall-anchored surface protein
with uniform migration on SDSyPAGE. Mutanolysin (Mu)
cleaves the glycan strands (29), solubilizing surface protein as a
spectrum of fragments with linked peptidoglycan. Mutanolysin
digestion of the peptidoglycan of strain SKM1 released unlinked
P2 precursor, demonstrating the inability of sortase mutants to
anchor surface proteins to the cell wall.
Staphylococcal Protein Secretion and Sorting Pathways. Precursor
proteins bearing N-terminal signal peptides are directed to the
secretion machinery of Gram-positive bacteria, translocated
across the cytoplasmic membrane, and secreted into the extra-
cellular environment. Surface proteins of S. aureus are initiated
into the secretion pathway, where the C-terminal sorting signals
function to retain surface proteins within the secretion machin-
ery, allowing processing at the LPXTG motif. We explored
whether sortase mutants were defective at a distinct step of cell
wall anchoring or caused a general disruption of the protein
secretion and sorting pathways. The staphylococcal cell wall is a
covalently linked network that is impermeable to proteins (1).
When pulse-labeled cultures are precipitated with trichloroace-
tic acid (TCA) and boiled in SDS, only secreted proteins are
solubilized. In contrast, staphylococcal surface proteins, mem-
brane, or cytoplasmic proteins require digestion of the cell wall
with lysostaphin for solubilization in hot SDS.
Fusion of the N-terminal signal peptide of enterotoxin B (Seb)
(30) to the mature domain of staphylococcal b-lactamase (BlaZ)
generated a hybrid protein (SebSP-BlaZ, 1) that is initiated into
the secretory pathway and translocated into the extracellular
medium by wild-type staphylococci (27) (Fig. 3). The sorting
signal of protein A (Cws) was placed into the center of a hybrid
polypeptide, f lanked at the N terminus by Seb and at the C
terminus by BlaZ (Seb-Cws-BlaZ, 2) (5). Wild-type staphylo-
cocci cleaved the Seb-Cws-BlaZ (2) precursor (P) at the LPXTG
motif and generated the mature C-terminal BlaZ fragment (M).
Both precursor and mature species were not secreted into the
medium. Removal of the LPXTG motif abolished precursor
cleavage of the hybrid protein (Seb-CwsDLPXTG-BlaZ, 3),
Fig. 2. Anchoring surface proteins to the cell wall of staphylococci. (A)
Drawing depicts the structure of the Seb-Cws surface protein, which is com-
prised of enterotoxin B (Seb) with an N-terminal signal peptide and a C-
terminal cell wall sorting signal. The cell wall sorting signal contains an LPXTG
motif, a hydrophobic domain (black box), and a positively charged tail. (B) The
sorting signals of protein A (Spa), fibronectin-binding protein (FnbA), and
clumping factor (ClfA) were fused to Seb, and cell wall sorting was followed
in a pulse–chase experiment. (C) Pulse-labeled staphylococci cultures were
fractionated into medium (MD), cell wall (CW), membrane (M), and cytosolic
(C) compartments, and Seb-Spa490–524 was immunoprecipitated with anti-Seb
(a-Seb). (D) The peptidoglycan of staphylococci was digested with lysostaphin
(L) or mutanolysin (Mu), and radiolabeled surface proteins were analyzed by
SDSyPAGE.
Fig. 3. Protein secretion and sorting pathways of staphylococci. (A) Drawing
depicts the structure of protein fusions with the mature domain of staphylo-
coccal b-lactamase (BlaZ). 1, (SebSP-BlaZ) fusion of the enterotoxin B signal
peptide (SP). 2, (Seb-Cws-BlaZ) fusion of enterotoxin B (Seb) and the protein
A sorting signal to BlaZ. 3, (Seb-CwsDLPXTG-BlaZ) same fusion as in 2 but lacking
the LPXTG motif. 4, (Seb-CwsDR-BlaZ) same fusion as in 2 but lacking the
retention signal (1). (B) Pulse-labeled staphylococcal cultures (strain RN4220)
were divided into two aliquots and precipitated with TCA. One sample was
directly boiled in SDS, whereas the other was first subjected to peptidoglycan
hydrolysis with lysostaphin and then boiled in SDS. Samples were subjected to
immunoprecipitation with anti-BlaZ (a-BlaZ) and analyzed by SDSyPAGE and
PhosphorImager. (C) Same experiment as in B, but using the sortase mutant
strain SKM1.
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whereas removal of the positively charged retention signal
caused the secretion of uncleaved precursor molecules into the
extracellular medium (Seb-CwsDR-BlaZ, 4). Sortase mutant cells
did not display a defect in the staphylococcal secretion pathway
as SebSP-BlaZ and Seb-CwsDR-BlaZ were found in the extracel-
lular medium. Sortase mutants failed to cleave Seb-Cws-BlaZ at
the LPXTG motif. Nevertheless, the hybrid protein required
lysostaphin digestion of the cell wall for solubility in hot SDS,
indicating that the polypeptide was retained within the secretory
pathway. Thus, sortase mutants are defective in the cleavage and
anchoring of surface proteins, but unaffected in the protein
secretion pathway.
Display of Surface Proteins by Staphylococci. We asked whether
sortase mutant strains were able to assemble and display surface
adhesins. Assembly of functional adhesins was examined by
incubation of staphylococci with specific ligands, i.e., mamma-
lian plasma and extracellular matrix proteins. CY3-labeled Ig
was added to staphylococci, and binding to protein A on the
bacterial surface was visualized by fluorescence microscopy (Fig.
4). S. aureus Newman (wild-type spa) bound CY3-labeled Ig on
the cell surface as revealed by the halo of fluorescence sur-
rounding bacteria. In contrast, the sortase mutants SKM1 and
SKM3 (srtA2) failed to bind CY3-labeled Ig. Binding was
restored to wild-type levels by transformation of the mutant
strains with plasmids encoding wild-type sortase (pSrtA). As a
control, S. aureus OS2 lacking the protein A gene (spa2) also did
not bind Ig, a defect that was corrected by the introduction of
plasmids specifying the wild-type spa gene.
We wondered whether the functional assembly of all staphy-
lococcal adhesins, protein A, fibronectin-binding proteins (FnbA
and FnbB), and clumping factors (ClfA and ClfB) may be
affected in the sortase mutant strains. Purified Ig, fibronectin, or
fibrinogen was immobilized on microtiter plates. Binding of
staphylococci to mammalian proteins was observed by staining
bacteria with crystal violet and measuring the absorbance at
570 nm in a spectrophotometer (Fig. 5) (31). The addition of
increasing amounts of Ig to microtiter dishes caused increasing
numbers of S. aureus RN4220 to bind to the coated plates.
Sortase mutant staphylococci (SKM1) failed to bind Ig, consis-
tent with the previous observation that the display of Spa on the
bacterial surface was indeed abolished. As a control, the Spa-
deficient strain OS2 did not bind to Ig-coated microtiter plates.
The addition of increasing amounts of fibronectin to microtiter
dishes caused increasing numbers of S. aureus RN4220 to bind
to the coated plates. The sortase mutation abolished all fibronec-
tin binding of strain SKM1. During exponential growth, S. aureus
Newman is known to display ClfA and ClfB, each of which
promotes binding to fibrinogen (17). In contrast to S. aureus
Newman, the isogenic sortase mutant, strain SKM3, failed to
bind fibrinogen. Thus, sortase is absolutely necessary for the
assembly and display of functional surface adhesins in the cell
wall envelope of staphylococci.
Surface Proteins and the Pathogenesis of S. aureus Infections.
S. aureus is a resident of the human skin and nares. What
distinguishes S. aureus strains from other microbes is their ability
to penetrate deeper layers of the skin, thereby causing suppu-
rative diseases or purulent wound infections. Following entry
into the blood stream, S. aureus escape phagocytic killing by
immune cells and, after binding to specific tissues, cause ab-
scesses in internal organs (32). To test whether surface adhesins
Fig. 4. Display of protein A on the staphylococcal surface. Binding of
CY3-labeled Ig to protein A was measured by capturing dark-field and fluo-
rescent microscopy images with a charge-coupled device camera and super-
imposing the data. S. aureus OS2 (spa2) cannot express protein A; however, Ig
binding was restored by transformation with plasmid encoding wild-type spa
(pSpa). S. aureus SKM1 (srtA:ermC) failed to bind CY3-labeled Ig, a defect that
was complemented by transformation with plasmids encoding wild-type srtA
(pSrtA). S. aureus Newman (wild-type, wt) displayed protein A on the staph-
ylococcal surface; however, the isogenic sortase knockout mutant SKM3 failed
to bind CY3-labeled Ig.
Fig. 5. Display of surface proteins by staphylococci. Microtiter dishes were
coated with increasing amounts of Ig, fibronectin, or fibrinogen. Binding of
staphylococci to mammalian proteins was detected by staining with crystal
violet and measuring the absorbance at 570 nm in a spectrophotometer. (A)
Binding of S. aureus RN4220 (r), OS2 (spa2, ), and SKM1 (srtA2, n ) to Ig. (B)
Binding of S. aureus RN4220 (r), and SKM1 (srtA2, n ) to fibronectin. (C)
Binding of S. aureus Newman (r) and SKM3 (srtA2, n ) to fibrinogen.
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are necessary for the pathogenesis of staphylococcal diseases, we
investigated the formation of renal abscesses in a mouse model
of infection (33). After injection into the tail vein of animals,
staphylococci escape phagocytic killing and infect kidney tissues
and produce renal abscesses after an interval of 5 days (34).
Quantification of viable bacteria within kidneys is a measure for
staphylococcal colonization and multiplication within tissues of
the infected host.
C57BLy6 inbred mice were injected with 5 3 105, 1 3 106, or
1 3 107 colony-forming units (cfu) of S. aureus Newman. Almost
all infected animals developed kidney abscesses (Fig. 6). The
number of viable staphylococci within these abscesses varied
between 5 3 104 and 8 3 107 cfu. This variation is likely because
of differences in the innate immune response between animals.
Injection of C57BLy6 mice with 5 3 105, 1 3 106, or 1 3 107 cfu
of the sortase mutant strain SKM3 revealed a dramatic reduction
in virulence. Almost all animals cleared the inoculum. Only two
animals developed abscesses with viable staphylococci (8 3 104
and 1 3 106 cfu, respectively). Similar results were observed with
outbred Swiss–Webster mice. On injection of 1 3 106 cfu,
S. aureus Newman caused kidney abscesses in almost all infected
animals. These lesions contained variable numbers of staphylo-
cocci (2 3 103 to 1 3 107 cfu), reflecting the inherent hetero-
geneity of the immune system of outbred mouse strains. Nev-
ertheless, almost all mice injected with 1 3 106 cfu of strain
SKM3 cleared the inoculum. Kidney abscesses of the sortase
mutant strain SKM3 could be observed on injection of 1 3 107
cfu. These abscesses contained on average 1y100 as many
staphylococci as similar lesions caused by infection with S. aureus
Newman.
Because of their ability to elicit an effective immune response,
infected mice can eventually clear almost all S. aureus infections.
Hence, after injection into the peritoneal cavity, large numbers
of staphylococci are required to cause a lethal infection (35).
Lethal infections are thought to measure the sum of all virulence
factors that bacterial pathogens elaborate (36). For example, in
addition to the display of surface adhesins, S. aureus secrete
numerous exotoxins and superantigens to manipulate the im-
mune system and escape phagocytosis. To evaluate the contri-
bution of surface proteins during the pathogenesis of acute
infections, staphylococci were injected into the peritoneal cavity
of CD1 mice (Table 1). In two independent experiments, wild-
type S. aureus Newman caused a lethal infection in half of all
infected animals when 8.09 3 106 cfu were injected into the
peritoneal cavity of CD1 mice. In contrast, the isogenic sortase
mutant strain SKM3 required 2.15 3 108 cfu to produce a lethal
disease in half of the infected animals. These data indicate that
the sortase mutant strain is significantly impaired in the ability
to produce an acute infection.
Discussion
S. aureus sortase is a membrane-anchored enzyme and is abso-
lutely required for the anchoring of all surface proteins to the cell
wall envelope. Biochemical studies revealed that sortase cleaves
surface protein precursors between the threonine and the gly-
cine of the LPXTG motif (5, 10). Anchoring occurs by a
transpeptidation reaction, and sortase captures the C-terminal
carboxyl of cleaved surface proteins by the formation of a
thioester bond with its active site sulfhydryl (10). Nucleophilic
attack of the amino group of the lipid II peptidoglycan precursor
presumably completes the sorting reaction, causing surface
proteins to form an amide bond with the cell wall crossbridge and
regenerating the active site sulfhydryl of sortase (37). Sortase
utilizes precursor molecules of both the protein secretion and
cell wall synthesis pathways as substrates for the transpeptidation
reaction (38). Determination of the subcellular distribution of
sortase in the cytoplasmic membrane may reveal how the
enzyme can gain access to these molecules.
Fig. 6. Surface proteins and the pathogenesis of S. aureus infections.
S. aureus Newman (human clinical isolate) and the isogenic sortase mutant
SKM3 were injected into the tail vein of C57BLy6 (A) or Swiss–Webster mice (B)
as indicated. Five days after infection, animals were killed, kidneys excised,
homogenized, and plated. Symbols indicate cfu of S. aureus Newman ( n ) and
the sortase mutant strain SKM3 (F). The dashed line represents the limit of
detection of staphylococci in renal tissues. P values were calculated after log
transformation of the data using the Student t test or the Mann–Whitney U
test (parenthesis): C57BLy6: 5 3 105 cfu, P 5 0.03 (0.08); 1 3 106 cfu, P 5 0.01
(0.04); 1 3 107 cfu, P 5 0.12 (0.11). Swiss–Webster: 1 3 106 cfu, P 5 0.049 (0.006);
1 3 107 cfu, P 5 0.0004 (0.001).
Table 1. Staphylococcal surface proteins are required to establish
acute infections in mice
S. aureus strain cfu injected Mortality, %
Experiment 1
Newman (wt) 1.25 3 108 90
Newman (wt) 1.25 3 107 90
Newman (wt) 1.25 3 106 0
SKM3 (srtA2) 1.35 3 108 20
SKM3 (srtA2) 1.35 3 107 0
SKM3 (srtA2) 1.35 3 106 0
Experiment 2
Newman (wt) 7.0 3 107 100
Newman (wt) 7.0 3 106 40
Newman (wt) 7.0 3 105 0
SKM3 (srtA2) 1.1 3 108 40
SKM3 (srtA2) 1.1 3 107 0
SKM3 (srtA2) 1.1 3 106 0
S. aureus strains Newman (wild-type) and the isogenic sortase mutant
SKM3 were grown overnight in TSB supplemented with 5% sheep’s blood at
37°C. The cultures were diluted 1;10 in fresh medium and incubated with
shaking for 5 h. Staphylococci were diluted into 5% hog gastric mucin, and 0.5
ml was injected i.p. into 10 CD1 mice per dilution. Animals were observed for
72 h, and moribund mice were euthanized. Average LD50 Newman 7.2 3 106
(Exp. 1), 7.58 3 106 (Exp. 2) and SKM3 1.8 3 108 (Exp. 1), 1.2 3 108 (Exp. 2)
(P , 0.05).
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Sortase likely plays a universal role in Gram-positive bacteria.
Surface proteins harboring C-terminal sorting signals with an
LPXTG motif have been found in all pathogenic Gram-positive
bacteria (1). Further, the amino group of the cell wall crossbridge
is a conserved feature of all of these microorganisms (39).
Sortase homologs have been identified in Actinomyces naeslundi,
Bacillus subtilis, Clostridium perfringens, Corynebacterium diph-
theriae, Enterococcus faecalis, Streptococcus mutans, Streptococ-
cus pneumoniae, and Streptococcus pyogenes (9). These homologs
may have a function similar to S. aureus sortase. For example,
Actinomyces naeslundi elaborate fimbriae that are composed of
subunits bearing C-terminal sorting signals with an LPXTG
motif (40). Fimbrial assembly is reported to depend on the
actinomycetal sortase homolog (41). Furthermore, characteriza-
tion of the anchor structure of surface proteins in Listeria
monocytogenes revealed that cell wall sorting occurs by a mech-
anism similar to that described in staphylococci (42).
We demonstrate here that sortase is essential for the func-
tional assembly of all surface proteins examined and for the
pathogenesis of S. aureus infections. Compounds that interfere
with sortase function may be useful for the treatment of human
infections caused by Gram-positive bacteria. Sortase inhibitors
should act as antiinfective agents and disrupt the pathogenesis of
bacterial infections without affecting microbial viability. Anti-
infectives may not exert selective pressure toward the develop-
ment of bacterial resistance. In contrast, antibiotics, which aim
to kill all microbes, do exert strong selective pressure, resulting
in the emergence of drug-resistant strains (43). Because of the
massive consumption of antibiotics, drug-resistant microbes
already predominate as human pathogens (44). Modern chemo-
therapy must consider the threat of antibiotic resistance and
target factors that are required for the pathogenesis of bacterial
infections.
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